4',4''',4'''''-Nitrilotris(([1,1'-biphenyl]-4-carbonitrile)), 97%, 250mg

2,5-Cyclohexadiene-1,4-dione, 2-(2,5-dichlorophenyl)-, 98%, 1g

METHYL 2-CHLOROQUINAZOLINE-5-CARBOXYLATE, 95.0%, 250mg

5-Bromo-2,3-dimethylpyridine, 95.0%, 10g

6-FLUORO-2-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg

1H-Pyrrolo[3,2-c]pyridin-4-amine, 95.0%, 250mg

1-[2-Amino-1-(2-chlorophenyl)ethyl]pyrrolidine-3-carboxylic acid hydrochloride, 97.0%, 250mg

Ethyl pyrrolo[2,1-f][1,2,4]triazine-7-carboxylate, 97%, 250mg

2-(pyrrolidin-2-yl)-1,3-oxazole dihydrochloride, 95.0%, 500mg

1-BOC-3-METHYLPYRROLIDINE-3-CARBOXYLIC ACID, 97.0%, 10g

4-(2-methoxybenzoyl)-8-methyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

2M trimethylamine in THF, 500ml

tert-Butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)oxy)silane, 98%, 1g